Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
50.19 SEK | -69.27% | -5.78% | -38.73% |
31/05 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
31/05 | Hansa Biopharma Completes Randomization in Pivotal Phase 3 Us Confides Trial | CI |